Rice Partnership’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,443
| Closed | -$247K | – | 131 |
|
|
2023
Q3 | $247K | Sell |
7,443
-6,536
| -47% | -$217K | 0.07% | 89 |
|
|
2023
Q2 | $513K | Sell |
13,979
-124,899
| -90% | -$4.58M | 0.14% | 68 |
|
|
2023
Q1 | $5.67M | Buy |
138,878
+2,499
| +2% | +$102K | 1.7% | 17 |
|
|
2022
Q4 | $6.99M | Buy |
136,379
+8,232
| +6% | +$422K | 2.21% | 15 |
|
|
2022
Q3 | $5.61M | Buy |
128,147
+26,897
| +27% | +$1.18M | 1.8% | 18 |
|
|
2022
Q2 | $5.31M | Buy |
101,250
+4,075
| +4% | +$214K | 1.86% | 18 |
|
|
2022
Q1 | $5.03M | Buy |
97,175
+48,188
| +98% | +$2.49M | 1.45% | 24 |
|
|
2021
Q4 | $2.89M | Buy |
48,987
+5,684
| +13% | +$336K | 0.82% | 33 |
|
|
2021
Q3 | $1.86M | Buy |
+43,303
| New | +$1.86M | 0.59% | 37 |
|
|
2021
Q1 | – | Sell |
-23,325
| Closed | -$859K | – | 117 |
|
|
2020
Q4 | $859K | Sell |
23,325
-870
| -4% | -$32K | 0.32% | 50 |
|
|
2020
Q3 | $842K | Sell |
24,195
-825
| -3% | -$28.7K | 0.37% | 42 |
|
|
2020
Q2 | $776K | Sell |
25,020
-1,620
| -6% | -$50.2K | 0.4% | 39 |
|
|
2020
Q1 | $825K | Sell |
26,640
-5,773
| -18% | -$179K | 0.55% | 37 |
|
|
2019
Q4 | $1.21M | Sell |
32,413
-3,672
| -10% | -$137K | 0.66% | 39 |
|
|
2019
Q3 | $1.23M | Sell |
36,085
-3,525
| -9% | -$120K | 0.77% | 33 |
|
|
2019
Q2 | $1.63M | Sell |
39,610
-2,077
| -5% | -$85.4K | 1.1% | 25 |
|
|
2019
Q1 | $1.68M | Hold |
41,687
| – | – | 1.22% | 26 |
|
|
2018
Q4 | $1.73M | Sell |
41,687
-4,612
| -10% | -$191K | 1.55% | 23 |
|
|
2018
Q3 | $1.94M | Sell |
46,299
-24,502
| -35% | -$1.02M | 1.22% | 27 |
|
|
2018
Q2 | $2.44M | Buy |
70,801
+442
| +0.6% | +$15.2K | 1.6% | 22 |
|
|
2018
Q1 | $2.37M | Buy |
70,359
+6
| +0% | +$202 | 1.58% | 20 |
|
|
2017
Q4 | $2.42M | Buy |
+70,353
| New | +$2.42M | 1.7% | 20 |
|